CDEK
← All trials

NCT06079346

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
May 1, 2024
Primary completion
Jun 1, 2026
Completion date
Jun 1, 2027
First posted
Oct 12, 2023
Last posted
Aug 13, 2024
Enrollment
455
Arms / groups
2 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.